![]() |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Categories list
AlcoholismAlzheimer's And Parkinson'sAnalgesicsAnti-inflammatoriesAntiallergicAntibioticsAnticonvulsantsAntidepressantsAntifungalsAntiparasiticAntiviralsArthritisAsthmaBirth ControlCancerCardiovascular DiseasesCholesterolDiabetesDiureticsErectile DysfunctionEye CareGastrointestinal TractH I VHypertensionMen's HealthMental DisordersMigraineMuscle RelaxantsNeurological DisordersObesityOsteoporosisRespiratory TractSkin CareSurgeryUrinary TractWomen's Health 15 May 2012 20:12:30
Việc sá» dụng thuốc chống trầm cảmViá c sá dá ng thuá c chá ng trá m cá m VOA Tiá ng Viá t Nhá ng thuá c thÆ á ng gá p là fluoxetin (Prozac, Sarafem), sertralin (Zoloft), paroxetin (Paxil), fluvoxamin ( Luvox ). Theo khuyá n cà o hiá n nay cá a Tá chá c Y tá Quá c tá (WHO), là c chá a cÆ n trá m cá m bá ng thuá c, ná u thuá c hiá u nghiá m ngÆ á i ta cho bá nh nhà n ...
09 May 2012 16:58:15
Jazz Pharmaceuticals Announces First Quarter 2012 Financial ResultsJazz Pharmaceuticals Announces First Quarter 2012 Financial Results Sacramento Bee Psychiatry Products: Net sales of the company's psychiatry products, including once-daily Luvox CRÂ (fluvoxamine maleate), FazaClo HD and FazaClo LD were $17.7 million for the first quarter of 2012. For the prior year period, net sales of psychiatry ...
08 May 2012 22:08:54
Jazz Pharmaceuticals Announces First Quarter 2012 Financial ResultsJazz Pharmaceuticals Announces First Quarter 2012 Financial Results MarketWatch (press release) Psychiatry Products: Net sales of the company's psychiatry products, including once-daily Luvox CRÂ (fluvoxamine maleate), FazaClo HD and FazaClo LD were $17.7 million for the first quarter of 2012. For the prior year period, net sales of psychiatry ...
08 May 2012 22:07:12
Jazz Pharmaceuticals Announces First Quarter 2012 Financial ResultsJazz Pharmaceuticals Announces First Quarter 2012 Financial Results PR Newswire (press release) Psychiatry Products: Net sales of the company's psychiatry products, including once-daily Luvox CRÂ (fluvoxamine maleate), FazaClo HD and FazaClo LD were $17.7 million for the first quarter of 2012. For the prior year period, net sales of psychiatry ...
01 May 2012 01:43:07
Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference ...Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference ... MarketWatch (press release) The company's marketed products in these areas include: Xyrem (sodium oxybate), Prialt (ziconotide intrathecal infusion), FazaClo (clozapine USP) HD and LD, Luvox CR (fluvoxamine maleate) and Elestrin (estradiol gel 0.06%).
27 Apr 2012 13:24:36
Jazzed up for M&A, VCs Get a ReturnJazzed up for M&A, VCs Get a Return Private Equity Hub (press release) The company's marketed products in these areas include: Xyrem (sodium oxybate), Prialt (ziconotide intrathecal infusion), FazaClo (clozapine USP) HD and LD, Luvox CR (fluvoxamine maleate) and Elestrin (estradiol gel 0.06%).
26 Apr 2012 22:17:15
Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA PharmaJazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma MarketWatch (press release) The company's marketed products in these areas include: Xyrem (sodium oxybate), Prialt (ziconotide intrathecal infusion), FazaClo (clozapine USP) HD and LD, Luvox CR (fluvoxamine maleate) and Elestrin (estradiol gel 0.06%).
|
|
Choose Your language:
Site search:
Testimonials
I have Received the Order .
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Bestsellers|Policies|Frequently Asked Questions|Testimonials|Contact us|Sitemap |
|
|
|
|
| |